Similarly, in ovarian carcinoma cells, paclitaxel-induced apoptosis is inhibited by ET-1 (via ETAR), triggering antiapoptotic signalling through bcl-2-dependent and phosphatidylinositol 3-kinase-mediated AKT pathways (Vacca et al, 2000). This evidence concerns the gene BCL2 and ovarian carcinoma.